Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
12,882,608
-
Share change
-
-148,799
-
Total reported value
-
$67,344,058
-
Put/Call ratio
-
0%
-
Price per share
-
$5.23
-
Number of holders
-
42
-
Value change
-
-$771,710
-
Number of buys
-
13
-
Number of sells
-
25
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q4 2014
As of 31 Dec 2014,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,882,608 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Pine River Capital Management L.P., FIL Ltd, BlackRock Fund Advisors, PICTET ASSET MANAGEMENT LTD, DEUTSCHE BANK AG\, Citadel Advisors LLC, and Invesco Ltd..
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.